FH and hemolytic-uremic syndrome: The age of patients was significantly higher in anti-FH-positive patients (7.7 ± 3 years) compared to typical HUS (1.95 ± 1.6 years) and anti-FH-negative aHUS groups (4.3 ± 4 years) (p < 0.001 and 0.02, respectively).